News Archive

Rockville, MD: December 10, 2019. Robovet Corporation, a Rockville, Maryland startup focused on building novel veterinary diagnostic imaging systems, today announced it has begun raising funds through an equity crowdfunding campaign on the Wefunder platform (www.Wefunder.com/robovet). Robovet’s novel MRI systems for veterinary diagnostic imaging, robotic surgery and image guided therapy are expected to dramatically reduce the costs of advanced diagnostic imaging and veterinary cancer treatment. The company, headed by veterinary radiologist MC Seward DVM, MS, MBA, utilizes novel magnetic systems initially developed within the Weinberg Medical Physics incubator. According to Dr. Seward, “When I learned about Robovet’s MRI and image-guided treatment technology, it was easy to see the potential applications to the broader veterinary market in advanced diagnostic imaging and innovative therapies for equine and small animal veterinary patients”. “Dr. Seward’s academic work in MRI-guided therapy and his entrepreneurial experience make him the ideal CEO for the company,“ stated Irving Weinberg, MD PhD, co-founder. About Robovet Corporation

ROCKVILLE, Md., Dec. 05, 2019 (GLOBE NEWSWIRE) — Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for orphan and rare diseases, as well as neurology announced today it has entered into a definitive merger agreement to acquire Aevi Genomic Medicine (NASDAQ: GNMX) in an all-stock transaction valued at approximately $16.1 million at closing, plus contingent value rights, or CVRs, for up to an additional $6.5 million in subsequent milestone payments on clinical or regulatory successes, or both.  Additionally, the Company is exploring strategic alternatives for its neurological assets as well as its one commercialized product Millipred®.

Xconomy Boston —  After joining AstraZeneca’s Boston Bio Hub incubator last year, Gatehouse Bio is now teaming up with the pharma company to identify potential drug targets in respiratory and cardiovascular diseases.

Under the collaboration, expected to last multiple years, Gatehouse will use its sRNAlytics platform to identify small RNA (sRNA) signatures, which the company says help in diagnosing and subtyping diseases from human samples. Financial terms were not disclosed.

Jay A. Perman will take over as chancellor of the University System of Maryland in January as Robert L. Caret steps down six months earlier than planned.

Caret had decided not to seek another five-year contract, and the system’s Board of Regents announced it had chosen Perman, the University of Maryland, Baltimore President, to succeed Caret in June.

But on Friday, the Board of Regents announced that University of Maryland, Baltimore’s provost and executive vice president, Bruce Jarrell, will take over as the interim president of the university early next year. In a letter to the University of Maryland, Baltimore community, Perman said that the Regents “has set my start date” as Jan. 6.

Image: https://www.umaryland.edu/

Ben Wu, the deputy secretary of the Maryland Department of Commerce, has been named as the new CEO for the Montgomery County Economic Development Corporation.

MCEDC is a public-private economic development nonprofit for the county.

The Montgomery County agency’s board of directors announced the appointment in a press release on Wednesday afternoon. Wu’s first day is Dec. 18.

Image: Ben Wu, Maryland’s deputy commerce secretary, has been named as the new CEO for the Montgomery County Economic Development Corporation. PHOTO FROM MONTGOMERY COUNTY ECONOMIC DEVELOPMENT CORPORATION

Newswise — The rise of additive manufacturing – or as it’s more commonly known, 3D printing – has enabled the rapid production of complex parts across many domains. As the techniques have become more refined, the semiconductor industry has taken note. But until recently, no one’s been able to form single-crystal materials – the building block of semiconductors – with traditional additive manufacturing processes.

Image: Johns Hopkins APL Takes 3D Printing of Electronic Parts to the Next Level

ROCKVILLE, Md., Dec. 2, 2019 /PRNewswire/ — Emmes today announced that it is part of a team of medical centers, universities and private industry supporting the development of a “universal influenza vaccine” that could provide longer-lasting protection than current vaccines and combat a wider variety of influenza viruses.

Gaithersburg, MD and Cambridge, MA – December 4, 2019: MaxCyte, the global cell-based therapies and life sciences company, and KSQ Therapeutics, a biotechnology company using its proprietary CRISPRomics® discovery platform to achieve higher probabilities of success in drug development, announced today that the companies have entered into a new development and commercialization agreement. Under the agreement, KSQ gains rights to use MaxCyte’s Flow Electroporation® technology and ExPERT™ instruments for the advancement of KSQ’s engineered tumor-infiltrating lymphocyte (eTIL™) programs, which the company is developing for the treatment of PD-1 refractory solid tumors.